Drug Shortage Report for NAPROXEN EC

Last updated on 2018-08-16 History
Report ID 49537
Drug Identification Number 02350807
Brand name NAPROXEN EC
Common or Proper name NAPROXEN EC TAB
Company Name SANIS HEALTH INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) NAPROXEN
Strength(s) 500MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size 100
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-06-15
Actual start date 2018-06-06
Estimated end date 2018-08-17
Actual end date 2018-08-15
Shortage status Resolved
Updated date 2018-08-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-08-16 English Compare
v9 2018-08-15 French Compare
v8 2018-08-15 English Compare
v7 2018-07-30 French Compare
v6 2018-07-30 English Compare
v5 2018-06-07 English Compare
v4 2018-06-06 French Compare
v3 2018-06-06 English Compare
v2 2018-05-16 French Compare
v1 2018-05-16 English Compare

Showing 1 to 10 of 10